Thyroid News

Self-reported health-related quality of life is negatively affected by a diagnosis of differentiated thyroid cancer, or DTC, but outlook does improve within a year, according to findings published in Thyroid.

Hypothyroidism is a condition commonly associated with weight gain, but no established eating plan has been shown to treat underactive thyroid.

The FDA will allow the marketing of the Fluobeam 800 Clinic Imaging Device and the Parathyroid Detection PTeye System, which are two devices used to identify parathyroid tissue during surgery.

Use of the term “cancer” at diagnosis may prompt individuals with low-risk lesions to choose aggressive treatment that could do more harm than good, according to an analysis published in British Medical Journal.

Nearly one-quarter of the best-selling prenatal multivitamins in the U.S. in 2016 and 2017 did not contain iodine, although most of those that included iodine contained the recommended amount per dose, according to research published in Thyroid.

MUNICH — Vandetanib induced tumor shrinkage that persisted throughout multiple treatment lines for patients with advanced unresectable medullary thyroid cancer, according to study results presented at European Society for Medical Oncology Congress.

MUNICH — The combination of lenvatinib and pembrolizumab appeared effective for a small cohort of patients with metastatic anaplastic or poorly differentiated thyroid carcinoma, according to study results presented at European Society for Medical Oncology Congress.

The use of thyroid ultrasound as initial imaging for older adults increased by more than 20% per year between 2002 and 2013, corresponding with an increased rate of low-risk thyroid cancer diagnoses during the same period, according to an analysis of Medicare claims data over 12 years.

The FDA expanded the breakthrough therapy designation of LOXO-292 to include treatment of certain patients with advanced RET fusion-positive thyroid cancer, according to the manufacturer.

WASHINGTON — In this video exclusive, Lindsay A. Bischoff, MD, assistant professor of medicine in the division of diabetes, endocrinology and metabolism at Vanderbilt University Medical Center and medical director of the Vanderbilt Thyroid Center, outlines pressing matters in ethics for endocrinologists. Bischoff, who is a member of the American Thyroid Association’s ethics committee, details how endocrinologists can take a more effective approach to their practice.